Zsolt E. Lavotha and Dr. James W. Warren, Jr. join Board


Princeton, NJ, June 1, 2005-Abeille Pharmaceuticals, Inc., a product development company focusing on the development and commercialization of novel dosage forms and unique, proprietary combinations of existing drugs, today announced the appointment of Zsolt E. Lavotha and Dr. James W. Warren, Jr. to its Board of Directors. Mr. Lavotha is currently President and CEO of Orexo AB, a product focused drug delivery company with headquarters in Sweden, and was previously President and CEO of Lavipharm Corp., a U. S. based R&D company focusing on solubilization, formulation and drug delivery. Dr. Warren was most recently Chairman and CEO of Banner Pharmacaps, Inc., a global drug delivery company. Prior to Banner, Dr. Warren was President and CEO of Solvay Pharmaceuticals, and founder of the Pharmaceutical Development Center at the Medical University of South Carolina.

"We are pleased to have both of these industry professionals join Abeille Pharmaceuticals' Board of Directors," stated Suresh Borsadia, President and CEO. "Both Mr. Lavotha and Dr. Warren have over 30 years of extensive operational and financial experience in the pharmaceutical industry. Their background, expertise, and respective drug delivery experiences will allow them to bring a valuable perspective to our board as we advance our product candidates and continue our evolution and growth."

Mr. Lavotha is currently serving on the board of directors for Orexo AB, NeuroNova AB a privately held biopharmaceutical company, and Medivir AB, a public (Swedish Stock exchange) research and development company. As President and CEO of Orexo AB, he transformed the company into a highly respected European drug delivery company by completing licensing deals, defining its strategic direction and building its infrastructure. Prior to Orexo AB, Mr. Lavotha was President and CEO of Lavipharm Corp. where he built the company from a start-up R&D based company to a globally active company. In addition, Mr. Lavotha has over 24 years of experience with large pharmaceutical companies on an international basis, including Pfizer, Wyeth, where he held positions with increasing responsibility, including Chief Executive of Europe, Middle East and Africa.

Dr. Warren, as the Chairman and CEO, led the world-wide operations of Banner Pharmcaps, resulting in the company's growth into a profitable global entity. Prior to Banner, Dr. Warren was President and CEO of Solvay Pharmaceuticals, Inc., an international chemical and pharmaceutical company. During his 12 years with Solvay he was Senior VP of R&D and the President and CEO for the last five years. In addition, he has served as the President and CEO of the Pharmaceutical Development Center in South Carolina, and currently serves on the National Advisory Board of the University of South Carolina's College of Pharmacy, and the Board of the National Nutraceutical Center.

About Abeille Pharmaceuticals

Abeille Pharmaceuticals, Inc. is a privately-held pharmaceutical company based in Princeton, New Jersey. The Company is focused on the formulation of products by applying advanced delivery technologies to existing drugs. These advanced delivery technologies include oral controlled release and transdermal delivery systems. The new products may benefit patients by requiring a lower dose of medicine, reduced side effects and easier administration of medication, thereby encouraging a patient to use the medication as prescribed. Abeille is dedicated to the development and commercialization of products that address unmet medical needs and improve the quality of life for patients. The Company's initial efforts are directed towards drugs used to treat oncology related discomforts, diabetes and metabolic disorders, and CNS disorders.

For more information, visit our website http://www.abeillepharma.com

For more information contact:

Suresh Borsadia

President and CEO






© Abeille Pharmaceuticals, Inc 2004 - 2012